Catherine Novack Stock Analyst Profile - Jones Trading Research Coverage - Stocknear

Catherine Novack

Stock Analyst at Jones Trading

(3.61)
# 2590
Out of 5,508 analysts
27
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

21 Stocks

Name Action PT Current % Upside Ratings Updated
AARD Aardvark Therapeutic...
Initiates Coverage On: Buy
33
16.16 104.21% 1 Oct 1, 2025
DYN Dyne Therapeutics
Initiates Coverage On: Buy
30
12.89 132.74% 1 Jun 26, 2025
CAPR Capricor Therapeutic...
Maintains: Buy
40 29
7.7 276.62% 2 Jun 25, 2025
FEMY Femasys
Maintains: Buy
10 6
n/a n/a 2 May 13, 2025
RGLS Regulus Therapeutics
Downgrades: Hold
8 7
n/a n/a 2 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Apr 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
45
67.68 -33.51% 1 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
11
2.5 340% 1 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
130
46.01 182.55% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Oct 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
12 16
7.18 122.84% 2 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
4.72 196.61% 1 Sep 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
5 13
2.21 488.24% 2 Aug 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
9.19 8.81% 1 Apr 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
3.23 581.11% 1 Feb 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Oct 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
160
0.61 26129.51% 1 Jul 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
11
n/a n/a 1 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
n/a n/a 1 Dec 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
45
n/a n/a 1 Oct 4, 2021